SENCE Study

Attention Joslin Patients:

Joslin Diabetes Center's COVID-19 pandemic hybrid care model allows patients to tailor their care with remote and in-person services, including telehealth visits. Please visit our main COVID-19 page for all this information in both English and Spanish. Please access COVID Pass the day of any on-site appointment to answer screening questions to receive a pass.

Currently, Joslin does not have a supply of COVID-19 vaccine. Vaccine availability and distribution are controlled by federal and state authorities. If the vaccine becomes available to us, Joslin will adhere to the state's plan for prioritized distribution. Please monitor the COVID-19 page on our website for updates.

Strategies to Enhance New CGM use in Early Childhood (SENCE)

Description:

A clinical trial to find out how well the continuous glucose monitor works in children less than 8 years old with T1D and whether an added program for parents/guardians can improve comfort with using the CGM and improve blood glucose control.

This study will include:

8 clinic visits and up to 6 phone calls over a 12 month period
Use of a Continuous Glucose Monitor (CGM)
Review of diabetes management and download of blood glucose meter
Physical exams, vitals, and A1c measurements
Questionnaires

Recruitment:

This study is no longer recruiting participants.

Contact:

Principal Investigator: Dr. Lori Laffel

CHS(#2016-28)